Delivery Order SPE2DR25D2005-SPE2DR26FF0U1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,560.42 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules (500 count) under a firm fixed-price contract. This non-set-aside award, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.67 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 6, 2025, to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Omeprazole DR 40 mg capsules (500-count units) under a firm fixed-price contract valued at $1,807.32. This is a non-set-aside competitive award with a completion date of November 17, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,538.44 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 20 mg capsules (1,000 count) under a firm fixed price contract. This non-set-aside award was issued on December 26, 2025, with an ultimate completion date of December 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $7,908.71 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 20 mg capsules (1,000 count) on July 17, 2025, with completion expected by July 18, 2025. This competitively awarded, firm fixed-price delivery order includes no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,902.72 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 10 mg capsules (30-count units). The contract employs firm fixed-price pricing with no set-aside designation, indicating open competition. Performance will be completed by January 9, 2026, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.16 to AmerisourceBergen Drug Corp on December 20, 2025, for the supply of Omeprazole DR 40 mg capsules in a quantity of 500 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 22, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Omeprazole DR 20 mg capsules in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order has a ceiling value of $1,472.29 and is scheduled for completion by September 5, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 10 mg capsules (30-count units) under a firm fixed-price contract valued at $1,747.70. The award was made on December 29, 2025, with an ultimate completion date of December 30, 2025, and represents a competitive award with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 20 mg capsules (1,000-count units) valued at $1,229.84. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 24, 2025, issued on September 23, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF0U1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,147.34 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 20 mg capsules (1,000 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a major pharmaceutical distributor serving federal healthcare programs, particularly military and veteran systems. This delivery order was issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent IDC provides a comprehensive pharmaceutical supply vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare operations globally. The award reflects the company's established capability to meet competitive federal procurement requirements and supply essential pharmaceutical commodities to the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/12/26 |